Up Close with Elranatamab
Last Updated: May 13, 2026
Discover more about elranatamab-bcmm (ELREXFIO™).
Related Resources:
Treatment Support Kit
Treatment Support Kit: Elranatamab
PQI
PQI: Elranatamab (Elrexfio) for the Management of Relapsed/Refractory Multiple Myeloma
Last Updated: 08/03/2025
Perspectives
OncolyticsToday: The Bispecific Antibody Revolution
Author: KELLY BRUNK
Last Updated: 04/01/2024
Find Similar Resources:
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Overview of BTCEs: Comparison of Bispecific T-Cell Engagers (BTCEs)
Last Updated: 09/09/2026
Up Close with Linvoseltamab
Last Updated: 06/29/2026
Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings
Last Updated: 07/01/2025
Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure
Last Updated: 07/01/2025
PQI
PQI Podcast
Patient Education Sheet
Patient Education Sheet
PQI: Ruxolitinib Extended Release for the Management of Myelofibrosis, Polycythemia Vera, and Graft-Versus-Host Disease
Last Updated: 10/21/2026
S11 E9: Keep Saying Yes: Living, Advocating, and Finding Purpose with Cancer
Last Updated: 10/22/2026
Rusfertide (Mimrylo)
Last Updated: 10/19/2026
Lirafugratinib (Lyrfigtu)
Last Updated: 10/19/2026